Why Skin Can Look Dull, and What Microcirculation Can Explain

About the Authors

Bertica M. Rubio, M.D.

Bertica M. Rubio, M.D.

Medical Director, Antiaging Regenerative Medicine Clinic | Board-Certified Physician | Dartmouth Medical School

Dr. Bertica M. Rubio is a board-certified physician and Medical Director of the Antiaging Regenerative Medicine Clinic in Redlands, California. She earned her Bachelor of Science degree from Loyola Marymount University and her Doctor of Medicine from Dartmouth Medical School (Geisel School of Medicine). She completed her pediatrics residency at UC Irvine Medical Center.

With decades of clinical experience, Dr. Rubio specializes in age management medicine, regenerative medicine, wound healing, and growth factor therapies. Her practice integrates evidence-based medical science with advanced aesthetic and regenerative treatments, helping patients achieve optimal health and youthful vitality.

Dr. Rubio is passionate about educating patients on the science behind skincare, facial rejuvenation, and non-invasive technologies like EMS (Electrical Muscle Stimulation) for facial toning. Her articles for PureLift LAB combine rigorous medical knowledge with practical guidance for achieving real, lasting results.

Andrew Conrad Barile, PT, DPT

Andrew Conrad Barile, PT, DPT

Doctorate of Physical Therapy (DPT), Licensed Physical Therapist (PT)

Dr. Andrew Conrad Barile is a Doctor of Physical Therapy and the CEO and Founder of Xtreem Pulse LLC. He earned his Doctorate in Physical Therapy from Daemen College and brings over two decades of clinical and entrepreneurial experience in pediatric physical therapy, craniosacral therapy, and medical device innovation. His deep understanding of human anatomy, muscle physiology, and therapeutic technology provides invaluable science-backed approach to facial rejuvenation and anti-aging solutions.

Daniel Grinberg, MD, FACS

Daniel Grinberg, MD, FACS

Board-Certified Otolaryngologist & Head and Neck Surgeon | Fellow, American College of Surgeons | Assistant Clinical Professor, Mount Sinai School of Medicine

Daniel Grinberg, MD, FACS is a Board-Certified Otolaryngologist and Head & Neck Surgeon at ENT and Allergy Associates in West Nyack, NY. He earned his medical degree from Columbia University College of Physicians and Surgeons, completed his Otolaryngology residency at New York University Medical Center, and serves as Assistant Clinical Professor at Mount Sinai School of Medicine. He is a Fellow of both the American College of Surgeons and the American Academy of Otolaryngology.

Dr. Grinberg's head-and-neck surgical perspective brings PureLift LAB readers a wider clinical lens — connecting at-home EMS practice to the underlying medical anatomy with the same scientific rigor we apply to every device specification.

Prof. Dr. med. Ivo Buschmann

Prof. Dr. med. Ivo Buschmann

Chair of Angiology, Medizinische Hochschule Brandenburg | Clinic Director, University Clinic for Angiology, Brandenburg University Hospital | Former Senior Consultant, Charité Universitätsmedizin Berlin

Prof. Dr. med. Ivo Buschmann is Chair of Angiology at the Medizinische Hochschule Brandenburg Theodor Fontane (MHB) and Clinic Director of the University Clinic for Angiology at the Brandenburg University Hospital. He completed his medical training at the University of Hamburg, served as a Max-Planck Society Fellow at the Max-Planck-Institute for Heart and Lung Research, and held senior consultant positions at the Charité Universitätsmedizin Berlin Campus Virchow before being appointed Chair at MHB in 2016.

Prof. Buschmann is one of Europe's leading authorities on arteriogenesis — the flow-driven growth and remodeling of blood vessels — with more than 150 peer-reviewed publications and several US and EU patents on devices that stimulate collateral blood vessel growth through controlled shear-rate therapy. His research connects mechanical and electrical stimulation to vascular adaptation, microcirculation, and tissue perfusion.

Prof. Buschmann's contributions bring PureLift LAB readers a vascular-biology perspective that complements our existing clinical, physical-therapy, and surgical-anatomy authorship — explaining how EMS stimulation engages not only facial muscles but also the microcirculation that supplies them, and why smart delivery matters at the level of blood flow as much as muscle contraction.

Dull skin is an appearance description, not a diagnosis of poor circulation. A face can look less luminous because of dryness, surface roughness, pigment variation, irritation, sleep loss, lighting, product residue, or changes in skin reflectance. Microcirculation is part of skin physiology, but it should not be used as the automatic explanation for every flat-looking complexion.

PureLift can support facial muscle engagement at motor-level settings. It does not have a direct clinical trial proving that PDM increases facial blood flow, raises oxygen, or restores brightness. Glow adds red and blue LED for skin-layer use, while the electrical engine and light remain distinct modalities. Keeping those mechanisms separate prevents an attractive theory from becoming an unsupported promise.

What people mean when they say dull

The word dull can describe low surface reflectance, uneven tone, visible dehydration, a tired expression, or simply an unfavorable photograph. The outermost skin surface strongly influences how light scatters. A rough or dry surface may look less luminous even when underlying blood flow is normal. Pigment, redness, and the color temperature of the room can also change the impression.

For that reason, the first response should be practical. Compare the skin in consistent daylight, review whether a new active product has caused irritation, and check whether the barrier feels tight or flaky. A gentle routine, adequate moisturization, and appropriate sun protection may be more relevant than trying to stimulate the face harder.

Where microcirculation belongs in the explanation

Small blood vessels supply living tissue, so microcirculation is biologically relevant. The approved cosmetic phrase is supports microcirculation, used only when the source and context justify it. It is not equivalent to increasing oxygen, providing tissue detoxification, or treating a vascular condition. A temporary color change after rubbing or stimulation does not identify the mechanism and is not proof of a durable skin benefit.

The evidence base includes low-amplitude electrical research in several contexts, but those studies vary in tissue, current, intervention, and outcome. Category-level findings cannot be automatically assigned to a PureLift setting. Exact low-setting output remains an engineering estimate pending final bench measurement, and levels 1 and 2 do not add facial muscle activation.

What PureLift is designed to do

Every PureLift model uses PDM, which combines Dynamic Modulation across 361 frequencies from 1,370 to 1,730 Hz with Triple-Wave and its three depth-oriented components. At higher output, the complete waveform and delivered current are designed to cross the motor threshold. Pro Plus and Glow reach up to 9 mA, while exact maxima for Face, Pro, and Pro Edition are not supplied.

That architecture supports a facial-fitness claim. It does not establish that PDM brightens skin by causing circulation. If a user's expression looks more awake after a well-run session, the observation can be described as an appearance, not as proof of increased oxygen or a repaired microvascular process. The article Better Circulation, Better Glow should be read with the same evidence boundary.

Glow adds a separate skin modality

PureLift Glow adds an OSRAM dual-wavelength LED, red at 634 nm and blue at 465 nm with a 464 nm peak. Its measured combined irradiance is 1.13 W per square metre and its combined fluence is 678 joules per square metre per ten-minute session under IEC 62471 measurement at 20 cm. Those figures describe optical output, not an at-skin clinical dose.

Wavelength evidence is specific. The strongest approved blue-light acne evidence in the v10 set is near 415 nm, which is different from Glow's 464 nm peak. Glow's cleared acne indication covers mild to moderate inflammatory acne, not severe or cystic acne, and the device is never used over the eyes or eyelids. These limits matter even in an article focused on glow.

What the low-amplitude literature can and cannot supply

Kolimechkov and colleagues reviewed physiological effects of microcurrent and its applications in exercise contexts. That literature can inform a cautious category discussion of low-amplitude electrical stimulation. It is not a PureLift complexion trial and does not establish that a setting makes every user's skin brighter. The source is PMID 36399190.

This is the general rule for mechanism claims. A study can support the process it measured under the conditions it tested. It cannot be stretched across a different waveform, a different tissue, and an unmeasured cosmetic outcome. For PureLift, the honest low-setting position is skin-layer support without claiming measured brand-specific results.

What Omatsu reported

Omatsu 2024 reported cosmetic and blood-flow endpoints at week eight in a prospective split-face controlled study, not a randomized trial. The multimodal device combined 40 to 190 kHz facial NMES with iontophoresis, LED, and cooling. Because all four modalities were used, the study cannot isolate facial NMES. It also was not an acute during-session measurement and was not a PureLift study. See PMID 38992992.

The 2026 correction disclosed that two authors were YA-MAN employees and that YA-MAN supplied the devices and instruments. It stated that the results and conclusions were unchanged. See PMID 41834264. Omatsu can be cited as multimodal week-eight evidence. It cannot prove that PDM, facial NMES alone, or a PureLift contraction causes blood flow, brightness, muscle growth, or a SMAS effect.

A more useful dull-skin routine

Start with the surface. Keep cleansing gentle, support the barrier, use sun protection, and avoid stacking irritating actives. If using PureLift, apply the approved conductive product and treat the electrical session as facial fitness. If using Glow, treat LED as a separate skin modality with its own specifications and limits. Do not raise EMS intensity in an attempt to force a complexion response.

Photograph in the same light and avoid judging the face only after product application, when serum reflectance can mimic glow. There is no guaranteed point at which skin looks brighter. Response varies with skin condition, routine, environment, and the modality being assessed.

When a device is not the main answer

A persistent change in color, new rash, marked pallor, yellowing, pain, or other concerning skin change deserves appropriate professional advice. Cosmetic dullness and a medical sign are not interchangeable. Even when the concern is ordinary texture or dryness, a dermatologist or qualified skincare professional may be better placed to assess irritation, pigment, acne, or barrier problems than an electrical device. PureLift should be chosen for facial muscle engagement, and Glow for its defined LED features, not as a universal explanation or treatment for every complexion concern.

The honest answer

Skin can look dull for many reasons, and microcirculation is only one possible part of the physiology. PureLift's strongest electrical claim is controlled facial muscle engagement at higher output. Glow adds wavelength-specific LED. Neither proposition requires an unsupported claim that PDM produces a verified oxygenation effect or restores circulation. Clear categories make the routine easier to understand and the results easier to judge.

Back to blog